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Background
Complement anaphylatoxin 5a (C5a) is a powerful
inflammatory mediator involved in the pathology of
inflammatory diseases such as chronic idiopathic
urticaria. C5a binds to two receptors, C5aR, a G pro-
tein-coupled receptor, and C5L2, a 7-transmembrane
receptor deficient in G protein coupling. The role of
C5L2 in human mast cells (huMC) is unknown. We
hypothesized that huMC express C5aR and/or C5L2 and
C5a activates huMC to produce pro-inflammatory med-
iators through one or both of these receptors.
Methods
C5aR and C5L2 expression on the huMC line, LAD2,
was analyzed by quantitative PCR and flow cytometry.
Degranulation was measured by b-hexosaminidase assay.
Eicosanoids and cytokines/chemokines production was
measured by ELISA and cytometric bead array. C5L2
expression was knocked-out using C5L2 shRNA lenti-
viral particles (LvP) and a stably C5L2- cell line was
selected for further analysis of C5L2 function.
Results
LAD2 expressed mRNA for C5aR and C5L2. However,
flow cytometry analysis showed that LAD2 expressed
surface C5L2 but not C5aR. C5a stimulated LAD2 to
produce TNF (22±1.3pg/ml), GM-CSF (15±0.4pg/ml),
MCP-1 (53±3.6pg/ml) and IP-10 (32±4.3pg/ml). C5a
failed to degranulate LAD2 and generate eicosanoids.
C5L2 shRNA LvP completely knocked-out C5L2 expres-
sion. C5L2-depleted LAD2 did not respond to C5a
while control shRNA-treated LAD2 did.
Conclusions
LAD2 express C5L2 but not C5aR, and C5a induces
production of cytokines/chemokines suggesting that
C5L2 is an excitatory receptor in huMC. Knock-down
of C5L2 abrogates C5a function. This is the first study
to demonstrate a functional role of C5L2 in huMC. The
observation that C5L2, not C5aR, may be more impor-
tant in complement-mediated activation of huMC may
provide novel insights into treatment of complement-
mediated inflammation.
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